Symposia: Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, MDS, Lymphoid Leukemias, Adult, Translational Research, CLL, Clinical Research, Genomics, Bioinformatics, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Real-world evidence, Treatment Considerations, Biological therapies, Immunotherapy, Immunology, Lymphoid Malignancies, Computational biology, Adverse Events, Myeloid Malignancies, Biological Processes, Emerging technologies, Technology and Procedures, Human, Study Population, Measurable Residual Disease , Imaging, Transplantation (Allogeneic and Autologous), Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, MDS, Lymphoid Leukemias, Adult, Translational Research, CLL, Clinical Research, Genomics, Bioinformatics, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Real-world evidence, Treatment Considerations, Biological therapies, Immunotherapy, Immunology, Lymphoid Malignancies, Computational biology, Adverse Events, Myeloid Malignancies, Biological Processes, Emerging technologies, Technology and Procedures, Human, Study Population, Measurable Residual Disease , Imaging, Transplantation (Allogeneic and Autologous), Omics technologies
Monday, December 9, 2024: 2:45 PM-4:15 PM
Room 6A
(San Diego Convention Center)
Moderators:
Ben K. Tomlinson, MD, University of California, Davis
and
Betty K. Hamilton, MD, Cleveland Clinic Foundation
Disclosures:
Tomlinson: BMS: Consultancy, Research Funding.
This session consists of abstracts describing investigation of biologic mechanisms of relapse and outcomes after allogeneic transplant.
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH